サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/10/31 | 4,225 | 4,300 | 4,225 | 4,285 | +60 | +1.4% | 118,900 |
2022/10/28 | 4,210 | 4,265 | 4,190 | 4,225 | +30 | +0.7% | 345,800 |
2022/10/27 | 4,210 | 4,230 | 4,135 | 4,195 | -15 | -0.4% | 135,200 |
2022/10/26 | 4,150 | 4,220 | 4,150 | 4,210 | +100 | +2.4% | 128,900 |
2022/10/25 | 4,140 | 4,150 | 4,085 | 4,110 | -50 | -1.2% | 90,700 |
2022/10/24 | 4,205 | 4,205 | 4,145 | 4,160 | -5 | -0.1% | 71,800 |
2022/10/21 | 4,195 | 4,215 | 4,145 | 4,165 | -65 | -1.5% | 75,100 |
2022/10/20 | 4,205 | 4,250 | 4,200 | 4,230 | +5 | +0.1% | 80,900 |
2022/10/19 | 4,280 | 4,285 | 4,225 | 4,225 | -40 | -0.9% | 77,000 |
2022/10/18 | 4,285 | 4,290 | 4,235 | 4,265 | +40 | +0.9% | 105,300 |
2022/10/17 | 4,310 | 4,325 | 4,225 | 4,225 | -110 | -2.5% | 96,600 |
2022/10/14 | 4,315 | 4,340 | 4,285 | 4,335 | +130 | +3.1% | 153,200 |
2022/10/13 | 4,200 | 4,230 | 4,190 | 4,205 | -10 | -0.2% | 111,100 |
2022/10/12 | 4,230 | 4,270 | 4,185 | 4,215 | +30 | +0.7% | 175,900 |
2022/10/11 | 4,155 | 4,220 | 4,155 | 4,185 | -70 | -1.6% | 168,200 |
2022/10/07 | 4,240 | 4,290 | 4,225 | 4,255 | -35 | -0.8% | 120,900 |
2022/10/06 | 4,230 | 4,315 | 4,220 | 4,290 | +80 | +1.9% | 148,200 |
2022/10/05 | 4,230 | 4,245 | 4,185 | 4,210 | +15 | +0.4% | 109,000 |
2022/10/04 | 4,140 | 4,195 | 4,120 | 4,195 | +105 | +2.6% | 125,700 |
2022/10/03 | 4,070 | 4,100 | 4,025 | 4,090 | +30 | +0.7% | 106,200 |
2022/09/30 | 4,095 | 4,125 | 4,050 | 4,060 | -25 | -0.6% | 137,100 |
2022/09/29 | 4,015 | 4,090 | 4,005 | 4,085 | +50 | +1.2% | 92,500 |
2022/09/28 | 3,995 | 4,035 | 3,970 | 4,035 | +10 | +0.2% | 142,400 |
2022/09/27 | 4,000 | 4,080 | 4,000 | 4,025 | +25 | +0.6% | 127,900 |
2022/09/26 | 3,985 | 4,015 | 3,980 | 4,000 | ±0 | ±0% | 163,100 |
2022/09/22 | 4,000 | 4,015 | 3,955 | 4,000 | -40 | -1% | 132,400 |
2022/09/21 | 4,020 | 4,045 | 3,970 | 4,040 | -20 | -0.5% | 122,200 |
2022/09/20 | 4,030 | 4,060 | 4,005 | 4,060 | +50 | +1.2% | 92,300 |
2022/09/16 | 3,980 | 4,040 | 3,980 | 4,010 | -5 | -0.1% | 178,300 |
2022/09/15 | 3,990 | 4,020 | 3,965 | 4,015 | +15 | +0.4% | 141,600 |
2022/09/14 | 3,990 | 4,020 | 3,970 | 4,000 | -15 | -0.4% | 212,800 |
2022/09/13 | 4,000 | 4,070 | 4,000 | 4,015 | -10 | -0.2% | 121,200 |
2022/09/12 | 4,060 | 4,060 | 4,000 | 4,025 | +25 | +0.6% | 66,300 |
2022/09/09 | 3,990 | 4,035 | 3,975 | 4,000 | +15 | +0.4% | 154,700 |
2022/09/08 | 3,965 | 4,000 | 3,965 | 3,985 | +70 | +1.8% | 102,300 |
2022/09/07 | 3,885 | 3,920 | 3,855 | 3,915 | -35 | -0.9% | 190,400 |
2022/09/06 | 3,985 | 4,005 | 3,935 | 3,950 | -60 | -1.5% | 108,300 |
2022/09/05 | 4,030 | 4,050 | 4,005 | 4,010 | -75 | -1.8% | 103,800 |
2022/09/02 | 4,060 | 4,095 | 3,990 | 4,085 | +45 | +1.1% | 199,300 |
2022/09/01 | 4,085 | 4,140 | 4,035 | 4,040 | -75 | -1.8% | 157,900 |
2022/08/31 | 4,120 | 4,140 | 4,065 | 4,115 | -95 | -2.3% | 244,000 |
2022/08/30 | 4,175 | 4,240 | 4,150 | 4,210 | +60 | +1.4% | 587,500 |
2022/08/29 | 4,105 | 4,175 | 4,090 | 4,150 | -50 | -1.2% | 138,400 |
2022/08/26 | 4,150 | 4,215 | 4,145 | 4,200 | +50 | +1.2% | 131,800 |
2022/08/25 | 4,150 | 4,195 | 4,140 | 4,150 | -35 | -0.8% | 120,200 |
2022/08/24 | 4,225 | 4,240 | 4,165 | 4,185 | -55 | -1.3% | 101,400 |
2022/08/23 | 4,250 | 4,260 | 4,205 | 4,240 | -30 | -0.7% | 111,600 |
2022/08/22 | 4,230 | 4,270 | 4,195 | 4,270 | +35 | +0.8% | 94,000 |
2022/08/19 | 4,245 | 4,260 | 4,210 | 4,235 | +15 | +0.4% | 145,800 |
2022/08/18 | 4,210 | 4,240 | 4,165 | 4,220 | +30 | +0.7% | 118,500 |
501~
550
件表示中 / 887件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 191,700円 | +4.0% | +25.4% | 2.76% | 8.85倍 | 1.17倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 290,600円 | +56.7% | +357.2% | 0.00% | 26.91倍 | 6.41倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 406,300円 | +3.9% | -3.3% | 3.05% | 9.44倍 | 1.24倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 59,100円 | +7.5% | - | 0.00% | - | 2.06倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 437,600円 | +22.8% | +113.0% | 4.34% | 11.67倍 | 1.07倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム